US Broker Ratings

Tenet Healthcare Corporation (THC) Stock Analysis: A Solid 18.26% Upside Potential in the Healthcare Sector

Tenet Healthcare Corporation (NYSE: THC) presents a compelling investment opportunity in the healthcare sector, boasting a significant market capitalization of $17.72 billion. As a leading player in the medical care..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Investor Outlook on Growth Potential Amidst Biotech Innovations

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a prominent player in the biotechnology sector, offers investors an intriguing opportunity with its focus on RNA-targeted medicines. With a market capitalization of $12.95 billion,..

Telix Pharmaceuticals (TLX) Stock Analysis: 167% Potential Upside Ignites Investor Interest

Telix Pharmaceuticals Limited (ASX: TLX), an Australian biopharmaceutical company specializing in radiopharmaceuticals for therapeutic and diagnostic applications, is capturing the attention of investors with its substantial potential upside of 167.02%...

Alkermes plc (ALKS) Investor Outlook: Exploring a Potential 54% Upside with Robust Analyst Support

Alkermes plc (NASDAQ: ALKS), an innovative force in the healthcare sector, stands out in the competitive landscape of specialty and generic drug manufacturing. Headquartered in Dublin, Ireland, this biopharmaceutical company..

ADMA Biologics Inc (ADMA) Stock Analysis: Evaluating a 33% Potential Upside in the Biotech Sector

ADMA Biologics Inc (NASDAQ: ADMA) is carving out a niche in the healthcare sector with its focus on developing and marketing specialty plasma-derived biologics. As a prominent player in the..

Royalty Pharma plc (RPRX) Stock Analysis: Unpacking an 18.10% Upside Potential in Biotech Royalties

Royalty Pharma plc (NASDAQ: RPRX), a key player in the biotechnology sector, offers a unique investment proposition through its robust royalty portfolio. With a market capitalization of $22.87 billion, Royalty..

Becton, Dickinson and Company (BDX) Stock Analysis: Navigating a Solid 4.33% Upside Potential

Becton, Dickinson and Company (NYSE: BDX) stands as a stalwart in the healthcare sector, a critical player in the Medical Instruments & Supplies industry. With a robust market capitalization of..

STERIS plc (STE) Stock Analysis: Unpacking the 10.26% Potential Upside

Investors with a keen eye on the healthcare sector should take note of STERIS plc (NYSE: STE), a pivotal player in the medical devices industry. Headquartered in Mentor, Ohio, STERIS..

HealthEquity, Inc. (HQY) Investor Outlook: Exploring a 29.84% Upside Potential in the Healthcare Sector

HealthEquity, Inc. (HQY), a prominent player in the Health Information Services industry, offers an intriguing investment opportunity within the healthcare sector. Based in Draper, Utah, the company provides a robust..

Jazz Pharmaceuticals (JAZZ) Investor Outlook: Why Analysts See a 24.94% Upside Potential

Jazz Pharmaceuticals plc (JAZZ) stands as a dynamic player in the biotechnology sector, commanding significant attention from investors due to its promising product portfolio and robust growth potential. Headquartered in..

Qiagen N.V. (QGEN) Investor Outlook: Exploring a Potential 11.46% Upside with Strong Buy Ratings

For investors keen on the healthcare sector, particularly in diagnostics and research, Qiagen N.V. (NYSE: QGEN) presents a compelling case with its robust growth potential and market positioning. With a..

TransMedics Group, Inc. (TMDX) Stock Analysis: A Healthcare Innovator with a 16.53% Upside Potential

TransMedics Group, Inc. (NASDAQ: TMDX) is a healthcare company that stands at the forefront of medical innovation, particularly in the field of organ transplant therapy. With a market capitalization of..

Bruker Corporation (BRKR) Stock Analysis: Navigating Growth Amidst a 7.86% Potential Upside

For investors with an eye on the healthcare sector, Bruker Corporation (BRKR) presents a compelling opportunity. With its current market cap standing at $7.29 billion, Bruker operates in the medical..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Navigating a 2.77% Potential Upside with a Strong Buy Rating

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a global powerhouse in the healthcare sector, has consistently demonstrated resilience in the competitive landscape of drug manufacturing. Despite its rich history and diverse..

Nuvalent, Inc. (NUVL) Stock Analysis: A 36% Upside Potential in the Biotech Arena

Nuvalent, Inc. (NASDAQ: NUVL) is capturing the spotlight in the biotechnology sector with a robust market capitalization of $8.08 billion. This clinical-stage biopharmaceutical company, headquartered in Cambridge, Massachusetts, is pioneering..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Evaluating a Potential 3.27% Upside

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) stands as a formidable player in the global healthcare sector, specializing in both specialty and generic drug manufacturing. Based in Hyderabad, India, the company’s..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Strong Buy Ratings and a Potential 23.56% Upside

Lantheus Holdings, Inc. (NASDAQ: LNTH) is making waves in the healthcare sector with its innovative diagnostic and therapeutic products. Based in Bedford, Massachusetts, Lantheus Holdings has been a key player..

Zoetis Inc. (ZTS) Stock Analysis: Uncovering a 25% Potential Upside in the Animal Health Leader

Zoetis Inc. (NYSE: ZTS) stands as a formidable player in the healthcare sector, specifically within the drug manufacturing industry focusing on specialty and generic products. With a market capitalization of..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Uncovering a 14.52% Potential Upside in the Medical Devices Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector specializing in medical devices, presents an intriguing case for investors seeking opportunities in the life sciences and clinical..

Illumina, Inc. (ILMN) Stock Analysis: Evaluating Its Market Position Amidst Mixed Analyst Ratings

Illumina, Inc. (NASDAQ: ILMN), a key player in the healthcare sector specializing in diagnostics and research, commands a significant presence in the genetic and genomic analysis market. Headquartered in San..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds